- Tytuł:
- Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors-protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID trial).
- Autorzy:
- Źródło:
- Trials [Trials] 2024 Feb 16; Vol. 25 (1), pp. 129. Date of Electronic Publication: 2024 Feb 16.
- Typ publikacji:
- Clinical Trial Protocol; Journal Article
- MeSH Terms:
-
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 1*/diagnosis
Diabetes Mellitus, Type 1*/drug therapy
Diabetes Mellitus, Type 1*/complications
Sodium-Glucose Transporter 2 Inhibitors*/adverse effects
Renal Insufficiency, Chronic*/diagnosis
Renal Insufficiency, Chronic*/drug therapy
Renal Insufficiency, Chronic*/complications
Humans ; Young Adult ; Adult ; Middle Aged ; Aged ; Hypoglycemic Agents/adverse effects ; Glucagon-Like Peptide 1 ; Obesity/complications ; Obesity/diagnosis ; Obesity/drug therapy ; Glucose ; Sodium ; Randomized Controlled Trials as Topic
Czasopismo naukowe